Sofosbuvir Metabolite GS-331007-13C, d3
Sofosbuvir Metabolite GS-331007-13C, d3 is listed under Metabolite and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Sofosbuvir. The product is supplied by Clearsynth under CAT No. CS-O-30476. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Product Specifications
Overview
"Sofosbuvir Metabolite-13CD3; Labeled Sofosbuvir, intended for use as an internal standard for the quantification of Sofosbuvir by GC- or LC-mass spectrometry."
CAS Number
1256490-42-2
Synonyms
Sofosbuvir Metabolite GS-331007-13C, d3
Molecular Formula
C 913 CH 10 D 3 FN 2 O 5
Molecular Weight
264.23
Additionnal Information
Sofosbuvir Metabolite GS-331007-13C, d3 is supplied with detailed characterization data compliant with regulatory guideline. Sofosbuvir Metabolite GS-331007-13C, d3 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Sofosbuvir.
Storage Conditions
Refer MSDS for complete information.
Applications Notes
"Sofosbuvir Metabolite-13CD3; Labeled Sofosbuvir, intended for use as an internal standard for the quantification of Sofosbuvir by GC- or LC-mass spectrometry."
HSN Code
38229010
Hazard Compound
Refer MSDS for accurate information.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBL1-09075 0.1 mg
CEBP epsilon Overexpression Lysate (Native) - (Dry Ice)
Sign In for Pricing
View Details 
MBS1366132-01 0.02 mg (E-Coli)
Recombinant Erwinia carotovora subsp. atroseptica 6-phosphogluconolactonase (pgl)
Sign In for Pricing
View Details MBS1366132-02 0.02 mg (Yeast)
Recombinant Erwinia carotovora subsp. atroseptica 6-phosphogluconolactonase (pgl)
Sign In for Pricing
View Details